InChI=1S/C24H30N2O2.ClH/c1- 2- 26- 19- 22(13- 14- 25- 15- 17- 28- 18- 16- 25) 24(23(26) 27,20- 9- 5- 3- 6- 10- 20) 21- 11- 7- 4- 8- 12- 21;/h3- 12,22H,2,13- 19H2,1H3;1H |
MBGXILHMHYLZJT-UHFFFAOYSA-N |
[Cl-].CCN1CC(CC[NH+]2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1 |
|
central nervous system stimulant
Any drug that enhances the activity of the central nervous system.
|
|
View more via ChEBI Ontology
4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chloride
|
(±)-doxapram HCl
|
ChEBI
|
(±)-doxapram hydrochloride (anhydrous)
|
ChEBI
|
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride
|
ChEBI
|
3,3-diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride
|
ChemIDplus
|
doxapram HCl
|
ChemIDplus
|
doxapram hydrochloride
|
ChemIDplus
|
113-07-5
|
CAS Registry Number
|
ChemIDplus
|
4171633
|
Beilstein Registry Number
|
Beilstein
|
|